Started Jun 27, 2021 03:00AM UTC   •   Closed Oct 01, 2021 07:01AM UTC

The Economist asks:

How many RNA vaccines and therapeutics for humans will be FDA-approved as of 2031?

Researchers see a great deal of potential in using ribonucleic acid (RNA) technologies in medicine (Nature, CNN). The outcome will be determined using FDA data available as of 31 December 2031. "Expanded access/compassionate use," "accelerated approval," and "emergency use" authorizations would not count (FDA - Expanded Access, FDA - Accelerated Approval, FDA - Emergency Use Authorization). Approvals of modified formulations of the same vaccine and/or therapeutic to treat different variants of the same disease would not count (e.g., Pfizer getting approval of a modified form of its vaccine to protect against a new variant of COVID-19).

This question will be suspended on 1 October 2021. While forecasts on this question may be evaluated in the years to come, they will not be scored.

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

This question has been voided by an administrator and is no longer active.

Long-term, unscored question
Tip: Mention someone by typing @username